JSM 2004 - Toronto

JSM Activity #305

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
Legend: = Applied Session, = Theme Session, = Presenter
FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center
Add To My Program
305 Theme Session Wed, 8/11/04, 8:30 AM - 10:20 AM TCC-713 B
Dose Studies - Contributed - Papers
Biopharmaceutical Section, SSC, Biometrics Section
Chair(s): Hongzi C. Chen, GlaxoSmithKline
     8:35 AM   A Group Sequential Approach to Evaluation of Bridging Studies — Chin-Fu Hsiao, National Health Research Institutes
     8:50 AM   Comparison of Different Analyses of Data from Sequential Designs with Applications in Drug Interaction Studies — Yonghua Wang, Bristol-Myers Squibb Company; Robert A. Smith, Bristol-Myers Squibb Company; Jingdong Xie, Bristol-Myers Squibb Company
     9:05 AM   A Model-based Approach in the Estimation of the Maximum Tolerated Dose in Phase I Cancer Clinical Trials — Weili He, Merck & Co., Inc.; Jun Liu, Rutgers University; Bruce Binkowitz, Merck & Co., Inc.; Hui Quan, Merck & Co., Inc.
     9:20 AM   Experimental Design for Combination Studies — Ming T. Tan, University of Maryland and Medicine; Hongbin Fang, University of Maryland and Medicine; Guoliang Tian, University of Maryland and Medicine
     9:35 AM   Comparative Dilution Bioassays: Parallel Line Approach vs. Converting through Standard Curve — Charles Y. Tan, Merck & Co., Inc.
     9:50 AM   Max-min Confidence Intervals for Differences between Treatments and Control for Monotone Dose-response Curves — Jianan Peng, Acadia University; Charles Lee, Memorial University of Newfoundland; Lin Liu, University of California, San Diego
     10:05 AM   Assessing the Joint Action of Multiple Drugs: Synergy, Additivity, and Antagonism — Xiaoli S. Hou, Merck & Co., Inc.; Keith A. Soper, Merck & Co., Inc.
 

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004